Zdrowie i gospodarka · 19/09/2019

FDA Requests Public Comment on Proposed Collection of Biologics License Application Information

The Food and Drug Administration is seeking public input on proposed changes to its general licensing provisions for biologics license applications, including labeling and postmarketing studies status reports, as required by the Paperwork Reduction Act of 1995.